ArticleFrontiers in oncology2026
An ultra-late maxillofacial cavity following multimodal treatment for adult head and neck rhabdomyosarcoma: a case report with a 16-year follow-up.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To report a rare case of a patient with adult rhabdomyosarcoma (RMS) in the craniofacial region who developed a very late-stage left maxillofacial cavity after 16 years of multimodal treatment, and to systematically investigate the potential causal relationship between this complication and previous radiotherapy. Methods: A detailed report is presented on the diagnosis and treatment process of a 46-year-old female patient. A comprehensive evaluation framework was employed to analyze causality, encompassing temporal correlation, spatial alignment with the original radiation field, exclusion of alternative etiologies, and biological plausibility. Results: Approximately 16 years after the initial radiotherapy, the patient developed soft tissue defects and cavity formation in the core area of the original high-dose irradiation field. Although tissue biopsy was not performed due to post-radiotherapy site bleeding and patient constitution risks, imaging studies showed a high degree of consistency between the lesion and the previous radiotherapy area, with no evident evidence of tumor recurrence or primary infection, consistent with the pathophysiological process of radiation-induced tissue necrosis. Conclusion: Despite the exceedingly long latency period, based on the conclusive spatial correlation, reasonable exclusion of other etiologies, and well-established radiobiological mechanisms, there is a "highly probable" causal relationship between the maxillofacial cavity and previous radiotherapy. This case serves as a warning that for long-term surviving RMS patients, extremely late radiation injury represents a serious complication risk that cannot be ignored.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.